Q & M Dental Group (Singapore) Ltd
SGX:QC7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (2.7), the stock would be worth S$0.3 (48% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 5.3 | S$0.59 |
0%
|
| 3-Year Average | 2.7 | S$0.3 |
-48%
|
| 5-Year Average | 3.2 | S$0.35 |
-40%
|
| Industry Average | 2.4 | S$0.26 |
-55%
|
| Country Average | 1.2 | S$0.13 |
-77%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| SG |
|
Q & M Dental Group (Singapore) Ltd
SGX:QC7
|
552.5m SGD | 5.3 | 59.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
102.9B USD | 1.4 | 58.2 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
70.3B EUR | 1.9 | 13.6 | |
| US |
|
Cigna Corp
NYSE:CI
|
75.1B USD | 1.8 | 12.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.6B EUR | 1.7 | 23.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23B EUR | 1.2 | 18.2 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.7B USD | 2.9 | 21.2 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.3B USD | 2.5 | 24.3 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 0.8 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
10.9B USD | -109.3 | -26.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | -15.8 | 13.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.8 |
| Median | 1.2 |
| 70th Percentile | 1.9 |
| Max | 474.4 |
Other Multiples
Q & M Dental Group (Singapore) Ltd
Glance View
Q & M Dental Group (Singapore) Ltd. is an investment holding company, which engages in the provision of management and consultancy services. The principal activities of the Company are the provision of management and consultancy services and investment holding. The company operates through the Primary Healthcare and Medical Laboratory and Dental Equipment and Supplies segments. The Primary Healthcare segment comprises dentistry, family medicine, aesthetic services, and others. The Medical laboratory and dental equipment and supplies segment comprises of sale and distribution of Covid-19 test kits and provision of laboratory testing and distribution of dental supplies and equipment. Its services are categorized as dental and medical, such as general health services, preventive care, vaccinations, extensive medical check-ups, minor procedures, and covid-19. Its dental services include aesthetic/cosmetic dentistry, dental x-rays, orthodontics (braces), teeth whitening, crowns and bridges, extractions, and mouth guards.
